Modality
Bispecific Ab
MOA
USP1i
Target
MDM2
Pathway
Checkpoint
Obesity
Development Pipeline
Preclinical
~Apr 2012
→ ~Jul 2013
Phase 1
~Oct 2013
→ ~Jan 2015
Phase 2
~Apr 2015
→ ~Jul 2016
Phase 3
~Oct 2016
→ ~Jan 2018
NDA/BLA
Apr 2018
→ Mar 2028
NDA/BLACurrent
NCT04326247
227 pts·Obesity
2018-04→2028-03·Terminated
227 total pts1 indication
Approved
CompletedCurrentUpcoming
Catalysts (1)
2028-03-172.0y awayPh3 Readout· Obesity
Trial Timeline
Q2Q3Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2
NDA/BLA
Termina…
Catalysts
Ph3 Readout
2028-03-17 · 2.0y away
Obesity
Terminated|StartCompletionToday
Trials (1)
| NCT | Phase | Indication | Status | N | EP |
|---|---|---|---|---|---|
| NCT04326247 | NDA/BLA | Obesity | Terminated | 227 | Safety |
Competitors (10)